Gibson, Dunn & Crutcher LLP

Gibson, Dunn & Crutcher LLP’s life sciences practice represents biotech, pharma, and medical device companies in IP and corporate and commercial transactions. The firm has a strong transactional team advising both issuers and financial institutions in deals across M&A, venture financing, stock and asset acquisitions, and private and public securities offerings. Its patent litigation expertise includes cases under the Hatch-Waxman Act, as well as the enforcement of second- and third-generation, combination drug, and formulation patents. The practice is co-chaired by San Francisco’s Ryan Murr, who is vastly experienced in capital markets transactions, M&A, royalty financing, and corporate governance. Also co-chair, New York-based Jane Love handles high-value patent litigation, patent prosecution, and diligence advice connected to transactions.